HeartSciences Inc. has secured its first commercial SaaS revenue agreement with St. Vincent Health to deploy its MyoVista Insights platform, marking a key milestone from early adopter installations to revenue-generating deployments. MyoVista Insights is a cloud-based ECG management system that integrates AI to improve clinical workflows and is device-agnostic, designed to scale across healthcare facilities. The company expects more commercial agreements in the coming quarters as it gains market interest following its full launch at the American College of Cardiology Annual Scientific Session. This deal highlights HeartSciences' transition to mainstream commercial operations and its potential growth in healthcare technology adoption.
Law Offices of Howard G. Smith reminds investors of upcoming deadlines to file lead plaintiff motions in securities fraud class actions involving Badger Meter, PicS N.V., Verra Mobility, and Grail, Inc. The lawsuits allege these companies made mislea...
Assembli Events & Production is creating the Big Ten Conference's first fan activation at Fanatics Fest NYC, held July 16-19, 2026. This event marks the Big Ten as the first collegiate conference to join the premier sports fan festival, showcasing tr...
State Street posted strong Q2 results with earnings per share of $3.65, beating estimates and up from $2.53 last year. Quarterly revenue reached $4.05 billion, driven by a 17.2% rise in fee revenues and 18% growth in net interest income. Assets under...
U.S. farmers face high and unstable fertilizer prices due to global shipping disruptions, with nearly 70% unable to afford needed fertilizer this season. Denali Water Solutions provides a natural, low-cost fertilizer alternative made from recycled or...
Denodo Technologies released Platform 9.5, improving its AI data layer by providing trusted, governed enterprise context for AI, analytics, and data sharing. Key features include an expanded enterprise knowledge graph, metric views for consistent bus...
